T15024 |
Silmitasertib sodium salt
|
1309357-15-0
|
99.49%
|
|
Silmitasertib sodium salt (CX-4945 sodium salt) is a potent and orally bioavailable, highly selective inhibitor of CK2(IC50 of 1 nM, CK2α).
|
T2259 |
Silmitasertib
|
1009820-21-6
|
99.47%
|
|
Silmitasertib (CX-4945) is a potent, orally bioavailable inhibitor of casein kinase 2 (CK2; Ki: 0.38 nM).
|
T60295 |
Casein kinase 1δ-IN-1
|
851871-94-8
|
99.46%
|
|
Casein kinase 1δ-IN-1 (WAY-643895) is an inhibitor of casein kinase 1δ (CK1δ), which inhibits CK1δ. Casein kinase 1δ-IN-1 can be used in the study of neurodegene...
|
T2695 |
TBB
|
17374-26-4
|
99.45%
|
|
TBB (NSC-231634)(NSC-231634) is a highly selective, ATP/GTP-competitive inhibitor of casein kinase-2 (CK2).
|
T60067 |
WAY-297174
|
442571-27-9
|
99.43%
|
|
WAY-297174 is a human protein kinase CK2 inhibitor with IC50 of > 33 μM.
|
T3073 |
PF-670462
|
950912-80-8
|
99.42%
|
|
PF-670462 is a potent (IC50 = 7.7 ± 2.2 nM) and selective (>30-fold with respect to 42 additional kinases) inhibitor of CK1ε in isolated enzyme preparations.
|
T64350 |
Casein kinase 1δ-IN-3
|
349438-77-3
|
99.42%
|
|
Casein kinase 1δ-IN-3 (Casein kinase 1δ-IN-3) (Compound 23a) is a casein kinase 1 delta (CK1d) inhibitor with a pIC50 of 6.5376 M.
|
T71339 |
BMS-863233 HCl
|
1169562-71-3
|
99.42%
|
|
BMS-863233 HCl is an ATP-competitive Cdc7 inhibitor (IC50: 3.4 nM) that is potent and selective.BMS-863233 HCl inhibited CK2 and PIM1 with IC50 values of 215 and...
|
T16528 |
PI-828
|
942289-87-4
|
99.39%
|
|
PI-828 is a phosphatidylinositol 3-kinase (PI3K) inhibitor, which is widely used to study the physiological function of PI3K and also promotes stem cell differen...
|
T21915 |
TBCA
|
934358-00-6
|
99.31%
|
|
TBCA (Casein Kinase II Inhibitor III, TBCA) is a highly selective CK2 (casein kinase II) inhibitor, IC50 = 110 nM, Ki = 77 nM. TBCA shows selectivity for CK2 ove...
|
T6208 |
AS-252424
|
900515-16-4
|
99.26%
|
|
AS-252424 is a potent and selective inhibitor of PI3Kγ with IC50 of 33 nM; >10 fold selectivity for PI3Kγ versus PI3Kα.
|
T6315 |
MLN8054
|
869363-13-3
|
99.05%
|
|
MLN8054 is a potent and selective Aurora A kinase inhibitor with an IC50 of 4 nM.
|
T77500 |
Casein kinase 1δ-IN-6
|
1579991-01-7
|
99%
|
|
Casein kinase 1δ-IN-6 is a potent and selective inhibitor of the protein kinase CK-1δ with an IC50 of 23 nM.Casein kinase 1δ-IN-6 shows neuroprotective and anti-...
|
T10827 |
CK2/ERK8-IN-1
|
1085822-09-8
|
98.82%
|
|
CK2/ERK8-IN-1 (TMCB) is a dual inhibitor of casein kinase 2 (CK2) (Ki: 0.25 µM) and ERK8 (IC50s: 0.50 μM) with pro-apoptotic efficacy. CK2/ERK8-IN-1 also binds t...
|
T10687 |
Casein Kinase II Inhibitor IV
|
863598-09-8
|
98.81%
|
|
Casein Kinase II Inhibitor IV is an inducer of epidermal keratinocyte differentiation.
|
T5393 |
CK1-IN-1
|
1784751-20-7
|
98.79%
|
|
CK1-IN-1 (PUN51207), compound 1c reported in patent WO2015119579A1, is a casein kinase 1 (CK1) inhibitor. It has IC50s of 15 nM, 16 nM, 73 nM for CK1δ, and CK1ε,...
|
T60005 |
CK1-IN-3
|
349438-74-0
|
98.70%
|
|
CK1-IN-3 is casein kinase 1 (CK1) inhibitor and can be used for research on the treatment or prevention of diseases associated with circadiantiazol rhythm, infla...
|
T13004 |
SSTC3
|
1242422-09-8
|
98.65%
|
|
SSTC3 is a casein kinase 1α (CK1α) activator with a Kd of 32 nM.SSTC3 has potential antitumor activity, inhibits WNT signaling, and suppresses SHH medulloblastom...
|
T77708 |
Casein kinase 1δ-IN-7
|
764694-25-9
|
98.6%
|
|
Casein kinase 1δ-IN-7 is a Casein kinase 1δ inhibitor for neurodegenerative diseases such as Alzheimer's disease.
|
T12237 |
NMS-P715
|
1202055-32-0
|
98.41%
|
|
NMS-P715 is a selective and ATP-competitive MPS1 inhibitor(IC50 of 182 nM).
|